Winton Group’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92.4K Sell
24,200
-22,000
-48% -$106K ﹤0.01% 1094
2026
Q1
$245K Buy
+46,200
New +$285K 0.01% 926
2021
Q4
Sell
-2,348
Closed -$87K 1422
2021
Q3
$87K Sell
2,348
-1,572
-40% -$57.8K ﹤0.01% 1294
2021
Q2
$191K Sell
3,920
-1,043
-21% -$43.5K 0.01% 1352
2021
Q1
$147K Buy
4,963
+2,907
+141% +$81.4K 0.01% 1312
2020
Q4
$53K Buy
+2,056
New +$41.3K ﹤0.01% 1288
2019
Q4
Sell
-12,464
Closed -$181K 1779
2019
Q3
$181K Buy
12,464
+10,757
+630% +$175K ﹤0.01% 1405
2019
Q2
$31K Sell
1,707
-609
-26% -$13.8K ﹤0.01% 1108
2019
Q1
$82K Buy
+2,316
New +$91.5K ﹤0.01% 1037

Other funds holding VSTM

Winton Group's VSTM Position: Q2 2026 in Review

Winton Group reduced its Verastem (VSTM) stake by 48% in Q2 2026, selling an estimated $106K and leaving 24,200 shares worth $92.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

Winton Group first reported a position in VSTM in Q1 2019 and has held it in 9 quarters since. The position peaked at $245K in Q1 2026. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Winton Group held 24,200 shares of Verastem worth $92.4K as of Q2 2026.
  • Winton Group sold 22,000 Verastem shares in Q2 2026, an estimated $106K.
  • Verastem made up ﹤0.01% of Winton Group's portfolio in Q2 2026, its #1094 holding.
  • Winton Group first reported a position in Verastem in Q1 2019 and has held it in 9 quarters since.
  • Winton Group's Verastem position peaked at $245K in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.